牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

毕得医药（688073）

3.9

综合诊断：3.9分打败了24%的股票！

卖出
减持
中性
增持
买入

短期趋势：
该股处于空头行情中，可能有短期反弹。
中期趋势：
-
长期趋势：
已有104家主力机构披露2024-12-31报告期持股数据，持仓量总计1354.75万股，占流通A股32.01%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

1.4分

4.7分

5.6分

2.5分

5.8分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：1.4技术面打败了2%的股票技术面评分前10的股票

近期的平均成本为48.19元。

技术面得分最高的股票

平均成本

近期的平均成本为48.19元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"48.19","date":1743585708,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。

[{"date":"2025.04.03","stock":"-5.07","trade":"-0.63","ind":"-0.24"},{"date":"2025.04.02","stock":"-0.02","trade":"-0.72","ind":"0.05"},{"date":"2025.04.01","stock":"0.85","trade":"4.21","ind":"0.38"},{"date":"2025.03.31","stock":"2.79","trade":"-1.68","ind":"-0.46"},{"date":"2025.03.28","stock":"-11.15","trade":"-0.93","ind":"-0.67"},{"date":"2025.03.27","stock":"-0.37","trade":"1.35","ind":"0.15"},{"date":"2025.03.26","stock":"-0.44","trade":"0.38","ind":"-0.04"},{"date":"2025.03.25","stock":"-1.82","trade":"-0.29","ind":"-0.00"},{"date":"2025.03.24","stock":"5.58","trade":"-1.95","ind":"0.15"},{"date":"2025.03.21","stock":"-1.33","trade":"-2.49","ind":"-1.29"},{"date":"2025.03.20","stock":"0.66","trade":"-0.92","ind":"-0.51"},{"date":"2025.03.19","stock":"0.53","trade":"-0.68","ind":"-0.10"},{"date":"2025.03.18","stock":"2.94","trade":"1.37","ind":"0.11"},{"date":"2025.03.17","stock":"0.67","trade":"-0.92","ind":"0.19"},{"date":"2025.03.14","stock":"2.34","trade":"2.56","ind":"1.81"},{"date":"2025.03.13","stock":"-2.17","trade":"-1.37","ind":"-0.39"},{"date":"2025.03.12","stock":"-2.65","trade":"-0.50","ind":"-0.23"},{"date":"2025.03.11","stock":"-0.99","trade":"-0.81","ind":"0.41"},{"date":"2025.03.10","stock":"0.77","trade":"1.34","ind":"-0.19"},{"date":"2025.03.07","stock":"-1.51","trade":"-1.74","ind":"-0.25"},{"date":"2025.03.06","stock":"-1.76","trade":"2.33","ind":"1.17"}]

毕得医药,上证指数,医疗服务指数

压力支撑

该股压力位为48.46元，支撑位为46.59元。

[{"text":"\u538b\u529b\u4f4d","value":"48.46","date":1743609600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"46.59","date":1743609600,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.7资金面打败了65%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月04日 20:40

机构今日流向(万元)	-1479.84	机构5日流向(万元)	-5373.19
机构10日流向(万元)	-11149.72	机构20日流向(万元)	-23297.21

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少724.13万股，其中基金净减仓15家，主力净增仓29家，暂未发现中长期投资价值。

截止2024-12-31，共104家主力机构（基金104家），持仓量总计1354.75万股，占流通A股32.01%
其中，基金持仓与2024-06-30相比：
增仓：2家，增持 0.07万股
减仓：17家，减持 80.71万股
新出现在主力名单中：71家，持有1218.45万股
从主力名单中消失：42家，原持有1861.94万股

消息面诊股

诊断结果：5.6消息面打败了68%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	个人原因	2025-03-11
一般消息	股东大会	临时股东大会	2025-02-08
利好	股票增发	董事会通过	2025-01-28
一般消息	募资投向	公司购买资产	2025-01-14
一般消息	重大事项	关联交易	2025-01-14
一般消息	高管变动	因个人原因	2024-12-31
一般消息	高管变动	因个人原因	2024-12-13
一般消息	资产重组	公司股权转让	2024-11-16
一般消息	分红转增	不分配不转增	2024-08-29
一般消息	高管变动	因个人原因	2024-06-03
利好	分红转增	10派9元(含税)	2024-04-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：2.5行业面打败了38%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.04.03","price":"-0.24","value":"-0.63"},{"date":"2025.04.02","price":"0.05","value":"-0.72"},{"date":"2025.04.01","price":"0.38","value":"4.21"},{"date":"2025.03.31","price":"-0.46","value":"-1.68"},{"date":"2025.03.28","price":"-0.67","value":"-0.93"},{"date":"2025.03.27","price":"0.15","value":"1.35"},{"date":"2025.03.26","price":"-0.04","value":"0.38"},{"date":"2025.03.25","price":"-0.00","value":"-0.29"},{"date":"2025.03.24","price":"0.15","value":"-1.95"},{"date":"2025.03.21","price":"-1.29","value":"-2.49"},{"date":"2025.03.20","price":"-0.51","value":"-0.92"},{"date":"2025.03.19","price":"-0.10","value":"-0.68"},{"date":"2025.03.18","price":"0.11","value":"1.37"},{"date":"2025.03.17","price":"0.19","value":"-0.92"},{"date":"2025.03.14","price":"1.81","value":"2.56"},{"date":"2025.03.13","price":"-0.39","value":"-1.37"},{"date":"2025.03.12","price":"-0.23","value":"-0.50"},{"date":"2025.03.11","price":"0.41","value":"-0.81"},{"date":"2025.03.10","price":"-0.19","value":"1.34"},{"date":"2025.03.07","price":"-0.25","value":"-1.74"},{"date":"2025.03.06","price":"1.17","value":"2.33"}]

上证指数,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	诚达药业	18.04%	20.39%	4.2分
2	百花医药	11.14%	10.31%	5.2分
3	ST中珠	8.66%	-4.83%	5.9分
4	博腾股份	8.34%	-3.04%	4.7分
5	和元生物	6.60%	1.36%	4.6分
6	金凯生科	6.52%	2.81%	4.0分
7	普蕊斯	4.91%	3.47%	4.5分
8	博济医药	4.58%	4.69%	4.8分
9	九洲药业	3.88%	0.98%	5.2分
10	万邦医药	2.44%	2.09%	4.9分
11	华厦眼科	2.33%	-0.74%	5.0分
12	华康洁净	2.32%	2.73%	4.6分
13	药明康德	1.83%	-6.59%	4.4分
14	阳光诺和	1.33%	2.25%	5.3分
15	通策医疗	0.81%	-2.11%	5.1分
16	百诚医药	0.40%	2.04%	4.8分
17	诺思格	0.38%	5.19%	5.4分
18	睿智医药	0.15%	6.64%	5.3分
19	海特生物	-0.48%	6.51%	4.8分
20	南华生物	-0.79%	0.91%	4.4分
21	康龙化成	-1.92%	-2.28%	5.4分
22	凯莱英	-3.79%	-3.26%	4.8分
23	盈康生命	-4.40%	-2.11%	5.3分
24	南模生物	-4.66%	3.21%	4.8分
25	爱尔眼科	-4.77%	-1.91%	5.1分
26	何氏眼科	-5.01%	1.39%	4.3分
27	益诺思	-5.28%	1.65%	4.7分
28	成都先导	-5.99%	3.89%	4.3分
29	皓元医药	-6.14%	-1.52%	5.5分
30	三博脑科	-6.88%	1.04%	3.9分
31	美迪西	-8.11%	0.94%	3.9分
32	昭衍新药	-8.33%	-9.92%	3.8分
33	国际医学	-9.39%	-1.58%	4.7分
34	药石科技	-9.81%	0.19%	3.8分
35	毕得医药	-10.92%	-12.57%	3.9分
36	药康生物	-11.24%	-2.21%	4.7分
37	兰卫医学	-11.33%	0.30%	3.7分
38	泰格医药	-11.63%	-7.38%	4.6分
39	新里程	-11.66%	-3.10%	4.5分
40	奥浦迈	-12.14%	-2.38%	4.8分
41	泓博医药	-15.18%	-0.22%	3.9分
42	迪安诊断	-15.62%	-3.11%	4.2分
43	普瑞眼科	-17.11%	5.85%	4.8分
44	诺禾致源	-17.45%	-0.20%	5.0分
45	美年健康	-17.54%	-0.35%	5.2分
46	贝瑞基因	-18.82%	-1.80%	4.3分
47	金域医学	-19.75%	-1.58%	4.3分
48	华大基因	-20.59%	-3.21%	3.7分
49	澳洋健康	-73.99%	0.87%	4.9分
50	-	-	153.01%	分
51	皓宸医疗	-	-3.47%	4.9分
52	光正眼科	-	-0.73%	4.7分
53	创新医疗	-	0.21%	3.2分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.8基本面打败了50%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/98 ， 21/98。

[{"date":"2024-09-30","value":"4.10","vol":"3.24"},{"date":"2024-06-30","value":"2.55","vol":"2.51"},{"date":"2024-03-31","value":"1.26","vol":"1.09"},{"date":"2023-12-31","value":"5.26","vol":"4.65"},{"date":"2023-09-30","value":"5.45","vol":"6.25"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	4.10	2.55	1.26	5.26	5.45
行业(%)	3.24	2.51	1.09	4.65	6.25

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"41.17","vol":"36.16"},{"date":"2024-06-30","value":"39.51","vol":"36.37"},{"date":"2024-03-31","value":"38.89","vol":"35.52"},{"date":"2023-12-31","value":"40.00","vol":"39.10"},{"date":"2023-09-30","value":"40.23","vol":"40.26"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	41.17	39.51	38.89	40.00	40.23
行业(%)	36.16	36.37	35.52	39.10	40.26

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 28/98 ， 24/98。

[{"date":"2024-09-30","value":"0.79","vol":"0.87"},{"date":"2024-06-30","value":"1.83","vol":"0.65"},{"date":"2024-03-31","value":"4.05","vol":"3.42"},{"date":"2023-12-31","value":"30.94","vol":"9.42"},{"date":"2023-09-30","value":"36.78","vol":"8.42"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	0.79	1.83	4.05	30.94	36.78
行业(%)	0.87	0.65	3.42	9.42	8.42

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"-26.05","vol":"-161.08"},{"date":"2024-06-30","value":"-38.15","vol":"-107.95"},{"date":"2024-03-31","value":"-29.39","vol":"-51.90"},{"date":"2023-12-31","value":"-24.94","vol":"-0.50"},{"date":"2023-09-30","value":"15.69","vol":"-395.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	-26.05	-38.15	-29.39	-24.94	15.69
行业(%)	-161.08	-107.95	-51.90	-0.50	-395.32

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 25/98 ， 49/98。

[{"date":"2024-09-30","value":"0.34","vol":"0.31"},{"date":"2024-06-30","value":"0.23","vol":"0.20"},{"date":"2024-03-31","value":"0.11","vol":"0.10"},{"date":"2023-12-31","value":"0.46","vol":"0.44"},{"date":"2023-09-30","value":"0.34","vol":"0.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.34	0.23	0.11	0.46	0.34
行业(次)	0.31	0.20	0.10	0.44	0.32

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.68","vol":"14.25"},{"date":"2024-06-30","value":"0.46","vol":"8.86"},{"date":"2024-03-31","value":"0.23","vol":"4.59"},{"date":"2023-12-31","value":"1.07","vol":"19.43"},{"date":"2023-09-30","value":"0.79","vol":"11.49"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	0.68	0.46	0.23	1.07	0.79
行业(次)	14.25	8.86	4.59	19.43	11.49

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"3.89","vol":"12.23"},{"date":"2024-06-30","value":"15.40","vol":"10.05"},{"date":"2024-03-31","value":"18.34","vol":"0.36"},{"date":"2023-12-31","value":"22.83","vol":"24.23"},{"date":"2023-09-30","value":"-27.49","vol":"16.29"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	3.89	15.40	18.34	22.83	-27.49
行业	12.23	10.05	0.36	24.23	16.29

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.27","vol":"1.44"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.49","vol":"2.47"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	0.27	-	1.49	-
行业	0.00	1.44	0.00	2.47	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 45/98 ， 42/98。

[{"date":"2024-09-30","value":"6.84","vol":"4.12"},{"date":"2024-06-30","value":"7.35","vol":"4.14"},{"date":"2024-03-31","value":"7.55","vol":"4.40"},{"date":"2023-12-31","value":"8.22","vol":"4.25"},{"date":"2023-09-30","value":"7.90","vol":"4.27"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	6.84	7.35	7.55	8.22	7.90
行业	4.12	4.14	4.40	4.25	4.27

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"4.49","vol":"3.38"},{"date":"2024-06-30","value":"4.95","vol":"3.40"},{"date":"2024-03-31","value":"5.18","vol":"3.62"},{"date":"2023-12-31","value":"5.54","vol":"3.54"},{"date":"2023-09-30","value":"5.26","vol":"3.71"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	4.49	4.95	5.18	5.54	5.26
行业	3.38	3.40	3.62	3.54	3.71

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/98 ， 45/98。

[{"date":"2024-09-30","value":"15.06","vol":"30.96"},{"date":"2024-06-30","value":"14.65","vol":"31.59"},{"date":"2024-03-31","value":"14.13","vol":"30.95"},{"date":"2023-12-31","value":"13.48","vol":"32.01"},{"date":"2023-09-30","value":"13.75","vol":"30.91"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	15.06	14.65	14.13	13.48	13.75
行业(%)	30.96	31.59	30.95	32.01	30.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.18","vol":"0.84"},{"date":"2024-06-30","value":"0.17","vol":"0.87"},{"date":"2024-03-31","value":"0.16","vol":"0.92"},{"date":"2023-12-31","value":"0.16","vol":"1.06"},{"date":"2023-09-30","value":"0.16","vol":"1.73"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	0.18	0.17	0.16	0.16	0.16
行业(%)	0.84	0.87	0.92	1.06	1.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
兴业证券	2025-03-04	增持
开源证券	2025-02-04	买入

机构预测

机构预测该股2024年每股收益与前一年相同，长期投资价值一般。

[{"date":"2020","yellowRectValue":"0.59","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.98","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.46","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.10","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.20","blueLineValue":"1.32","type":"YC"}]

[毕得医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]